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Invite your representative to work. Change the 
world. Here’s how.
ABSTRACT Today’s political climate can seem hostile to science. Alternative facts, climate 
change denial, and relabeling of actual news as fake news are discouraging phenomena for 
sure. But these trends make it more important than ever to engage our politicians. Take 
heart! There is something you can do. You can show your representatives firsthand the amaz-
ing things you do, evidence of the economic engine that your activities generate, and the real 
people behind the discoveries. I did, and it was fun. We invited our congressman to the 
University of California, Santa Barbara (UCSB), and he accepted! For 2 hours, we explained 
and demonstrated efforts to cure blindness using stem cells, the medical implications of the 
discovery that cells can recover from the brink of death, a mosquito lab striving to eliminate 
insect-borne disease, and an Alzheimer’s disease laboratory. Salud Carbajal peered through 
a microscope and met real scientists. Before his visit, he did not know what a postdoctoral 
fellow was, much less what stem cells look like. When he left he knew our names, how much 
money we bring into his district, and how important National Institutes of Health funding and 
international mobility are to our enterprise. Although I live in the United States, this approach 
should also apply to other democratic countries. If each of us converts one representative 
into a science champion, we can change the world.
HOW DO I GO ABOUT INVITING MY REPRESENTATIVES?
One day, I received an email from ASCB encouraging me to invite 
my congressional representative to work. Ordinarily, I would have 
immediately clicked “delete.” Though I would have thought that 
it sounded like a good idea, I would have had no clue how to go 
about it. However, on this day, a new synaptic connection flick-
ered, and I recognized instead that I had recently met someone 
who might be able to help. I was serving on a search committee, 
composed of people from across our campus, for a new vice 
chancellor for research. Each time we introduced ourselves, I 
heard that Monica was from the Office of Government Relations, 
though I had no inkling what that office did. Suddenly it occurred 
to me what they might do. So, instead of “delete,” I clicked “for-
ward” and asked Monica whether this was something her office 
could help us arrange. Her immediate reply was “Absolutely, 
that’s exactly the type of outreach our office organizes! … This is 
a great idea, and I appreciate you reaching out!” Very soon, we 
were planning the itinerary. So if you would like to invite your 
representative to work, contact your Office of Government Rela-
tions, which might be called something slightly different such as 
the Congressional Liaison Office. It turns out all universities have 
them. Who knew?
WHAT SHOULD THE ITINERARY LOOK LIKE?
Our goal was to engage and educate our congressman. Two post-
docs from my husband’s lab had recently attended a town hall meet-
ing. When they introduced themselves to our newly elected repre-
sentative, Salud Carbajal, they discovered that he did not know 
what a postdoctoral fellow was. Having graduated from UCSB, he 
was certainly familiar with the university, but he was unfamiliar with 
the science side of campus. We had the luxury of 2 hours with our 
representative. So we crafted a mixture of PowerPoint presentations 
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itinerary. He was engaged, duly impressed, and asked questions. 
Next, we wanted to get him into the lab, so we organized a tour and 
hands-on activity in the stem cell laboratory (Figure 1). Congress-
man Carbajal first learned about how stem cells are made and their 
great potential for curing diseases, including macular degeneration. 
Then he went into the lab, put on a lab coat and gloves, and got to 
peer into the microscope to see what these powerful cells look like 
(Figure 1).
His next stop was my office, where I told him of our discovery 
that cells can recover from the brink of apoptotic cell death. I 
showed him a movie of cells shriveling up and coming back to life. I 
told him how dependent we are on the National Institutes of Health 
(NIH) and shared with him the burning questions that make us jump 
out of bed every morning. Will enhancing cellular recovery from the 
brink of death be useful in limiting the damage due to heart attacks 
and strokes? Would selective inhibition of this recovery improve 
cancer treatment and prevent relapse? If we don’t stay funded, we 
will never know. We let him chew on that thought while we walked 
to the cell culture room and our live-imaging microscope. Along the 
way, he met postdocs from Armenia, China, and India, a technician 
from Ethiopia, and trainees from places closer to home like Irvine, 
San Diego, and, of course, Santa Barbara. He saw with his own eyes 
how important international mobility is for the U.S. research 
enterprise.
and lab demonstrations. We introduced him to graduate students, 
postdocs, faculty, and administrators. We kept him moving, so as 
not to bore him, and stuck to a strict schedule. Representatives are 
busy. Everyone wants a piece of them.
Our itinerary started with an overview of research at UCSB, pre-
sented by our vice chancellor for research (the same one Monica 
and I had helped hire into the position). His name is Joseph Incan-
dela, and he was one of the major leaders of the international team 
of particle physicists who discovered the Higgs boson or God par-
ticle. That is about as famous as scientists get, so our congressman 
had heard of him and his team’s discovery. Next, our dean of math-
ematical, life, and physical sciences spoke. He is also a physicist, and 
he frequently says that if he were starting out today, he would go 
into the life sciences. So that was a nice transition into the rest of our 
program. Our next presentation was from a charismatic graduate 
student who had recently won our Grad Slam competition. This is a 
contest among students from across the university for the best 
3-minute presentation of their research. Students compete through 
multiple rounds, and our own Leah Foltz had won the grand prize 
(which includes $5000 cash!). This event started at UCSB in 2013 
and became so popular that it has spread to all 10 UC campuses. 
Now the winners from each campus compete in a UC-wide event, 
and Leah had just won the People’s Choice Award there. So we were 
excited to include her 3-minute presentation in the congressman’s 
FIGURE 1: Clockwise from top left: Congressman Salud Carbajal, postdoctoral fellow Varuzhan Balasanyan, technician 
Adishti Gurav, PhD student Junjie Luo, PhD student Nick DeBeaubien, Congressman Carbajal, Congressman Carbajal, 
technician Cassidy Arnold, postodoctoral fellow Brittney Pennington, Congressman Carbajal. PhD student Nick 
DeBeaubien, Congressman Carbajal, Professor Craig Montell, Congressman Carbajal, Center photo: Congressman 
Carbajal with Professor Denise Montell.
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get questions about when your research project is likely to generate 
a cure. We have to emphasize that research is a long-term invest-
ment. Today’s new medicines were someone’s bright idea 10 or 20 
years ago. Give specific examples. For me, this is easy. I am alive 
today because of a monoclonal antibody (mAb) called Rituxan. mAb 
therapy was touted as a “magic bullet against cancer” in the late 
1970s and early 1980s. However, it took 20 years for the first mAb 
therapy to achieve clinical utility. That is because there were unan-
ticipated hurdles. It took decades to identify the problems and de-
velop the technologies to address them. Today, there are dozens of 
mAbs approved for clinical use. If we do not keep investing in fun-
damental knowledge, the pipeline will dry up, and there will be no 
new medicines 5 or 10 or 20 years from now. This is a key but chal-
lenging point to make.
A related challenge is neither over- nor underselling our achieve-
ments and the promise of our ongoing studies. Most scientists un-
derstandably tend to be conservative in this regard. We want to 
maintain our credibility and be sure not to overpromise and then 
fail to deliver. However, if we are too conservative, we don’t make 
a compelling case. So we have to walk that tightrope. Be prepared 
to answer the question about when your studies will produce ac-
tual treatments. Give a best-case scenario but be honest that there 
may be unanticipated challenges and setbacks that cause delays. 
Answer that the nature of research is that we cannot know in ad-
vance. Repeat that today’s cures were someone’s bright idea 10 or 
20 years ago and that we have to continually invest or the pipeline 
will dry up.
WHAT ARE THE REWARDS?
This experience was extremely rewarding, and I thank Kevin Wilson, 
the ASCB public policy advocate for suggesting it! The feedback we 
received from Congressman Carbajal’s office was very positive. 
Monica wrote, “I would like to thank you all for making the time to 
meet with Congressman Carbajal this afternoon. Everything went 
very smoothly, and he went out of his way to express how impressed 
he was with everything he heard and saw. I think we got across the 
message of the importance of federal funding in the biomedical sci-
ences very well. I want to especially thank Denise for all the work she 
put into the agenda and logistics.”
The most important reward is that we educated our representa-
tive about what we do and potentially converted someone who 
would have been reasonably supportive of federal funding for re-
search into a champion of our cause. If your representatives are not 
already fans of the NIH, perhaps such a visit will sway them. If, like 
Carbajal, they are starting out with a positive view, perhaps the visit 
will convert them into true advocates, not only voting the right way 
but also persuading others to do so. At a minimum, we will have 
more informed representatives. Additionally, my institution actually 
thanked me! Furthermore, this event motivated the vice chancellor 
for research to learn more about the life sciences on campus. As a 
prominent particle physicist, he is an extremely intelligent and curi-
ous man. I am delighted that he returned a few months later and 
spent several hours learning about a variety of projects going on in 
our department. I even received an email just the other day in which 
he said he had come across a popular science article that made him 
think of our work.
Finally, the visit made all of us—students, postdocs, faculty, 
and administrators—feel just a little bit more empowered. We 
live in a democracy. Our representatives need to hear from us. It 
is our duty as citizens. And if each of us converts one representa-
tive into a science champion, we can change the world for the 
better.
Salud’s next stop was Craig Montell’s lab, where he heard about 
their new efforts to apply the insights they have gleaned from study-
ing fruit fly behavior for 30 years to alter mosquito behavior in order 
to limit insect-borne diseases. This work makes the important point 
that basic research in model organisms can be used in many differ-
ent ways to combat human diseases. Craig Montell did not imagine 
30 or 20 or 10 years ago that his lab’s work on Drosophila might 
have an impact on zika or dengue. The congressman then took a 
tour of the mosquito lab and met more students and postdocs 
(Figure 1).
Congressman Carbajal’s final stop of the day was in Ken Kosik’s 
Altzheimer’s disease laboratory. Ken has been on 60 Minutes 
(www.mcdb.ucsb.edu/news/2016/alzheimers-laboratory), because 
he initiated a collaboration with a doctor in Colombia who had 
been treating a family that has a devastating incidence of early-
onset Alzheimer’s disease. This collaboration resulted in the iden-
tification of a mutation in the gene coding for Tau, which predicts 
with virtually 100% certainty which family members will get this 
debilitating disease. Potential treatments for Alzheimer’s are being 
tested in this family, because the Kosik team knows exactly who 
will get the disease and who does not carry the mutated allele. 
This makes the clinical trials more powerful than anything that can 
be carried out with the general population, in which the risks are 
much lower.
WHAT ARE THE SECRETS TO SUCCESS?
You already know the first secret. Knowing the office to contact to 
set it up is the first essential piece. Second, a good mix of renowned 
senior scientists and charismatic and diverse junior scientists keeps 
it interesting. A mix of lecture and active learning will also keep your 
visitors engaged and interested. The schedule was tight, and there 
was not quite enough time for all of his questions, but I think it was 
not so bad to leave him wanting to know more. We did not waste 
time traveling. He moved up or down one or two flights of stairs, 
getting to see a number of different offices and labs and a nice 
change of scenery, without sacrificing time. We offered water, cof-
fee, and cookies at every stop, where allowed by safety, but nothing 
extravagant.
WHAT ARE THE CHALLENGES?
Organizing this event was pretty straightforward. Everyone who 
was invited to participate did so eagerly and made time in their 
schedules. One challenge you might encounter is that many 
other people might hear about your event and want to partici-
pate. It is important to maintain control of the agenda. I did not 
have a big problem with this; however, there was one request for 
us to showcase research on campus funded by the Department 
of Defense (DoD), in part because Congressman Carbajal is a 
member of the Armed Services Committee. On one hand, it is 
important to recognize the congressman’s interests and where he 
wields power. On the other hand, DoD is under no threat of re-
duced funding, and because I had initiated the visit, I wanted to 
focus on NIH-funded research, which was threatened. Our vice 
chancellor did mention the large DoD-funded research enter-
prise at UCSB in his overview. But I quietly insisted that we keep 
the agenda focused on life science. I suggested that the Office of 
Government Relations invite the congressman back for another 
visit, and possibly many other visits, to highlight different parts of 
the campus.
A second challenge is that congressional representatives run for 
election every 2 years. Therefore, they are very interested in activi-
ties that are likely to yield fruit in that time frame. You will probably 
